Rheumatoid Arthritis Therapeutics Market

Future Market Insights

Key Insight

The rheumatoid arthritis therapeutics market is projected to grow from USD 27.2 billion in 2025 to USD 46.7 billion by 2035, at a CAGR of 5.6%. Biopharmaceuticals will dominate with a 88.6% market share, while prescription will lead the sales channel outlook segment with a 90.0% share.

September 22, 2025

Anurag Sharma

250 Pages

Cite this Report

Rheumatoid Arthritis Therapeutics Market

https://www.futuremarketinsights.com/reports/rheumatoid-arthritis-therapeutics-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Amgen
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb
F. Hoffmann-La Roche Ag
Johnson & Johnson Services
Lilly
Novartis
Regeneron Pharmaceuticals
UCB S.A

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Rheumatoid Arthritis Therapeutics Market

Key Players

Similar Industry Reports